Thymus Neoplasms: all 91 studies

Page 1 of 1. Open to participants first (22), then studies with results posted, then the rest; newest registration first within each.

• Hypofractionated Adjuvant Radiotherapy for Thymic Epithelial TumorsNot yet recruitingNCT07693855Not applicable
• An International Study on Pediatric Patients With Rare Tumors.RecruitingNCT07072143
• Prospective Data Collection Initiative on Thoracic MalignanciesRecruitingNCT06996249
• Neoadjuvant Radiotherapy for Locally Advanced Unresectable ThymomaRecruitingNCT06924619Phase 2
• Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including MesotheliomaRecruitingNCT06885697Phase 1
• Ivonescimab Combined with Chemotherapy As First-line Treatment of Relapsed or Metastatic Thymic Cancer: a Prospective, Single Arm, Phase II TrialNot yet recruitingNCT06750952Phase 2
• Glucocorticoids Combined With Concurrent Chemoradiotherapy for Unresectable ThymomaRecruitingNCT06730308Phase 2
• Hypofractionated Radiotherapy for Thymic Epithelial TumorsRecruitingNCT06692062Not applicable
• RATT Vs. VATT for Early-stage TETsNot yet recruitingNCT06654830Phase 2
• Artificial Intelligence Prediction Tool in Thymic Epithelial TumorsRecruitingNCT06301945
• Rivoceranib in Patients With Metastatic Thymic Epithelial TumorNot yet recruitingNCT06200233Phase 2
• Application of 68Ga-Pentixafor PET/CT for ThymomaRecruitingNCT06086327Early Phase 1
• Robot-assisted vs VATS for ThymomaRecruitingNCT06029621Not applicable
• Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.RecruitingNCT05918302Phase 3
• The Efficacy and Safety of Nanoparticle Albumin-bound (NAB)-Paclitaxel Plus Cisolation Versus CEP (Cisplatin, Epirubicin,Cyclophosphamide) in Induction Therapy for Thymoma: a Study for a Single-center Prospective Phase II Randomized Controlled Train.Not yet recruitingNCT05816694Phase 2
• A Study of KC1036 in Patients with Advanced Thymic TumorsRecruitingNCT05683886Phase 2
• Molecular Analysis and Treatment Options of Thymic MalignanciesRecruitingNCT05667948
• PT-112 in Subjects With Thymoma and Thymic CarcinomaRecruitingNCT05104736Phase 2
• Study on Proton Radiotherapy of Thymic MalignanciesRecruitingNCT04822077Not applicable
• French National Observatory of Patients With Thymic Epithelial TumorRecruitingNCT02724696
• Integrated Cancer Repository for Cancer ResearchRecruitingNCT02012699
• Molecular Analysis of Thoracic MalignanciesEnrolling by invitationNCT01385722
• Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid TumorsTerminatedNCT04234113Phase 1Results posted
• Selinexor in Patients With Advanced Thymic Epithelial Tumor Progressing After Primary ChemotherapyTerminatedNCT03193437Phase 2Results posted
• Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary MetastasesTerminatedNCT02859415Phase 1/2Results posted
• Ribociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut OriginCompletedNCT02420691Phase 2Results posted
• Pembrolizumab and Epacadostat in Patients With Thymic CarcinomaStatus unknownNCT02364076Phase 2Results posted
• Cognitive Testing of Tobacco Use Measurement Items for Administration With Cancer Patients and SurvivorsCompletedNCT02233842Results posted
• A Study of BKM120 (Buparlisib) in Relapsed or Refractory ThymomasCompletedNCT02220855Phase 2Results posted
• Efficacy of Medical Treatment With SOM230 LAR in Patients With Primary Inoperable Thymoma and/or With Local Recurrent Thymoma to Reduce Tumor SizeCompletedNCT02021942Phase 2Results posted
• Sunitinib for Advanced Thymus Cancer Following Earlier TreatmentCompletedNCT01621568Phase 2Results posted
• A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic MalignanciesCompletedNCT01364727Phase 2Results posted
• Study Of Oral PHA-848125AC In Patients With Malignant Thymoma Previously Treated With Multiple Lines Of ChemotherapyTerminatedNCT01301391Phase 2Results posted
• A Phase 1/2 Study of PXD101 (Belinostat) in Combination With Cisplatin, Doxorubicin and Cyclophosphamide in the First Line Treatment of Advanced or Recurrent Thymic, MalignanciesTerminatedNCT01100944Phase 1/2Results posted
• Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With ChemotherapyCompletedNCT00965250Phase 2Results posted
• Saracatinib in Treating Patients With Relapsed or Refractory Thymoma or Thymic CancerTerminatedNCT00718809Phase 2Results posted
• Belinostat (PXD101) to Treat Tumors of the Thymus at an Advanced StageCompletedNCT00589290Phase 2Results posted
• Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic CarcinomaCompletedNCT00198133Phase 2Results posted
• Carboplatin Combined With Paclitaxel in Treating Patients With Advanced ThymomaCompletedNCT00010257Phase 2Results posted
• Adjuvant Hypofractionation Radiotherapy for Thymic Epithelial Tumours After Complete ResectionActive, not recruitingNCT06189183Not applicable
• A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced CancersActive, not recruitingNCT05544929Phase 1
• Comparison of Single Port and Two Ports Robotic Assisted Thoracic Surgery for ThymectomyStatus unknownNCT05262582Not applicable
• IL-8+ naïve T Cells as a Biomarker for Thymoma IdentificationCompletedNCT05255965
• Surgery for Masaoka-Koga I-II ThymomaCompletedNCT05001113Not applicable
• A Phase 2 Clinical Study of YY-20394 in Patients With Relapsed/Refractory Thymic CancerStatus unknownNCT04975061
• Clinical Study of Neoadjuvant PD-1 Antibody (Toripalimab) Plus Chemotherapy for Locally Advanced Thymic Epithelial TumorStatus unknownNCT04667793Phase 2
• Prognostic Factors in Patients Submitted to Surgical Treatment for ThymomaCompletedNCT04577495
• Chemotherapy Combined With Pembrolizumab in Treating Patients With Thymoma and Thymic CarcinomaStatus unknownNCT04554524Phase 4
• Abscopal Effect of SBRT in Combination With rhGM-CSF and INF-α 2b for Metastatic Thymic Epithelial TumorsStatus unknownNCT04517539Phase 2
• Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various CancersActive, not recruitingNCT04459273Phase 1
• Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic CarcinomaActive, not recruitingNCT04417660Phase 2
• Single Cell Sequencing Analysis of ThymomaStatus unknownNCT04162691
• The Registry of Oncology Outcomes Associated with Testing and TreatmentCompletedNCT04028479
• Ramucirumab and Carbo-Paclitaxel for Untreated Thymic Carcinoma / B3 Thymoma With Carcinoma (RELEVENT)Active, not recruitingNCT03921671Phase 2
• neoadjuvant_thymic Epithelial TumorStatus unknownNCT03858582Phase 2
• Hypofractionated Chemoradiotherapy and Thymosin α1 in Unresectable or Recurrent Thymic Epithelial TumorStatus unknownNCT03663764Phase 2
• The Curative Effect of Extended Thymectomy Performed Through Subxiphoid-right VATS Approach With Elevation of SternumStatus unknownNCT03613272Not applicable
• Selinexor in Patients With Advanced Thymoma and Thymic CarcinomaStatus unknownNCT03466827Phase 2
• Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines (Style Trial)Status unknownNCT03449173Phase 2
• A Phase II Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial TumorStatus unknownNCT03219554Phase 2
• Preoperative Prediction of of Thymic Epithelial Tumors by Diffusion-Weighted MR ImagingStatus unknownNCT03212027
• Prospective Study of Stereotactic Body Radiation Therapy for Thymoma Inoma: Therapeutic Effect and Toxicity AssessmentCompletedNCT03078699Not applicable
• Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid TumorsCompletedNCT03023319Phase 1
• Regulation of LncRNA For Breg in Patients With Thymoma and Autoimmune DiseasesWithdrawnNCT02948855
• Cardiac MRI Biomarker Testing (GCC 1618)TerminatedNCT02688166
• Chemoradiotherapy for Limited Advanced Unresectable Thymic Epithelial TumorsCompletedNCT02636556Not applicable
• A Study of Pembrolizumab for Patients With Thymic Epithelial TumorCompletedNCT02607631Phase 2
• Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard TherapyCompletedNCT02307500Phase 2
• Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With ChemotherapyCompletedNCT02049047Phase 2
• Postoperative Conformal Radiotherapy for Stage II-III B Type ThymomaStatus unknownNCT02014805Phase 3
• Rapid Autopsy and Procurement of Cancer TissueTerminatedNCT01851395
• Genetic Evaluation of Families With Endocrine CancersCompletedNCT01794676
• 18F FLT Imaging Studies of Treatment Response for Lung Cancer and ThymomaWithdrawnNCT01610544Phase 2
• Neoadjuvant Chemotherapy for Locally Advanced Thymic CancerCompletedNCT01312324Phase 2
• Study of Hypofractionated Proton Radiation Therapy in Thoracic MalignanciesTerminatedNCT01165658Phase 1
• Heated Chemotherapy for Cancers That Have Spread to the Chest CavityCompletedNCT01163552Phase 2
• Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural MesotheliomasTerminatedNCT01143545Phase 1
• B-Receptor Signaling in CardiomyopathyCompletedNCT01135849
• Characteristics of Patients With Thymoma in Chulalongkorn HospitalCompletedNCT01123590
• The Role of the Thymus in Myasthenia GravisCompletedNCT01102192
• High Dose Somatostatin Analogues in Neuroendocrine TumorsCompletedNCT00990535Phase 2
• Biology of Thymic TumorsCompletedNCT00965627
• Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic MalignanciesCompletedNCT00921739Phase 1
• Paclitaxel and Cisplatin for Thymic NeoplasmTerminatedNCT00818090Phase 2
• Thoracic OncoGeriatric Assessment (TOGA) TrialsCompletedNCT00591981
• Preoperative Treatment of Patients With High Risk ThymomaCompletedNCT00387868Phase 2
• Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest CancerCompletedNCT00372840Not applicable
• A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic CancerCompletedNCT00369889Phase 2
• Efficacy of Octreotide Treatment in Patients With Primary Inoperable ThymomaCompletedNCT00332969Phase 2
• Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung CancerCompletedNCT00024076Phase 2
• Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent ThymomaCompletedNCT00003283Phase 2

← Thymus Neoplasms overview